Generic placeholder image

Current Radiopharmaceuticals

Author(s): Alban Revy, François Hallouard*, Sandrine Joyeux-Klamber, Andrea Skanjeti, Catherine Rioufol and Marc Fraysse

DOI: 10.2174/1874471012666190110170623

DownloadDownload PDF Flyer Cite As
Feasibility and Evaluation of Automated Methods for Radiolabeling of Radiopharmaceutical Kits with Gallium-68

Page: [229 - 237] Pages: 9

  • * (Excluding Mailing and Handling)

Abstract

Objectives: Recent gallium-68 labeled peptides are of increasing interest in PET imaging in nuclear medicine. Somakit TOC® is a radiopharmaceutical kit registered in the European Union for the preparation of [68Ga]Ga-DOTA-TOC used for the diagnosis of neuroendocrine tumors. Development of a labeling process using a synthesizer is particularly interesting for the quality and reproducibility of the final product although only manual processes are described in the Summary of Product (SmPC) of the registered product. The aim of the present study was therefore to evaluate the feasibility and value of using an automated synthesizer for the preparation of [68Ga]Ga-DOTA-TOC according to the SmPC of the Somakit TOC®.

Methods: Three methods of preparation were compared; each followed the SmPC of the Somakit TOC®. Over time, overheads, and overexposure were evaluated for each method.

Results: Mean±SD preparation time was 26.2±0.3 minutes for the manual method, 28±0.5 minutes for the semi-automated, and 40.3±0.2 minutes for the automated method. Overcost of the semi-automated method is 0.25€ per preparation for consumables and from 0.58€ to 0.92€ for personnel costs according to the operator (respectively, technician or pharmacist). For the automated method, overcost is 70€ for consumables and from 4.06€ to 6.44€ for personnel. For the manual method, extremity exposure was 0.425mSv for the right finger, and 0.350mSv for the left finger; for both the semi-automated and automated method extremity exposure were below the limit of quantification.

Conclusion: The present study reports for the first time both the feasibility of using a [68Ga]- radiopharmaceutical kit with a synthesizer and the limits for the development of a fully automated process.

Keywords: Gallium-68, positron-emission tomography radiolabeling, radiopharmaceuticals kit, automatisation, preparation, radiolabeling.

Graphical Abstract

[1]
Bauwens, M.; Chekol, R.; Vanbilloen, H.; Bormans, G.; Verbruggen, A. Optimal buffer choice of the radiosynthesis of (68)Ga-Dotatoc for clinical application. Nucl. Med. Commun., 2010, 31(8), 753-758.
[http://dx.doi.org/10.1097/MNM.0b013e32833acb99] [PMID: 20512080]
[2]
Sharma, V.; Sivapackiam, J.; Harpstrite, S.E.; Prior, J.L.; Gu, H.; Rath, N.P.; Piwnica-Worms, D. A generator-produced gallium-68 radiopharmaceutical for PET imaging of myocardial perfusion. PLoS One, 2014, 9(10)e109361
[http://dx.doi.org/10.1371/journal.pone.0109361] [PMID: 25353349]
[3]
Kilian, K. 68Ga-DOTA and analogs: Current status and future perspectives. Rep. Pract. Oncol. Radiother., 2014, 19(Suppl.), S13-S21.
[http://dx.doi.org/10.1016/j.rpor.2014.04.016] [PMID: 28443194]
[4]
Fani, M.; André, J.P.; Maecke, H.R. 68Ga-PET: A powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals. Contrast Media Mol. Imaging, 2008, 3(2), 67-77.
[http://dx.doi.org/10.1002/cmmi.232] [PMID: 18383558]
[5]
Summary of product of somakit n.d.. Available from http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004140/WC500221851.pdf [Accessed Jan. 5, 2018].
[6]
Bonnes pratiques de fabrication de médicaments à usage humain - ANSM : Agence nationale de sécurité du médicament et des produits de santé n.d.. Available from http://ansm.sante.fr/Activites/Elaboration-de-bonnes-pratiques/Bonnes-pratiques-de-fabrication-de-medicaments-a-usage-humain/(offset)/1 [Accessed Jan. 5, 2018]
[7]
World Health Organization (WHO). Guidelines on Good Manufacturing practices for radiopharmaceutical products, 2003.http://www.who.int/medicines/areas/quality_safety/quality_assurance/GMPRadiopharmaceuticalProductsTRS908Annex3.pdf
[8]
Cote, D.D.; Torchia, M.G. Robotic system for i.v. antineoplastic drug preparation: description and preliminary evaluation under simulated conditions. Am. J. Hosp. Pharm., 1989, 46(11), 2286-2293.
[http://dx.doi.org/10.1093/ajhp/46.11.2286] [PMID: 2589345]
[9]
Raimbault, M.; Thibault, M.; Lebel, D.; Bussières, J-F. Automated compounding of parenteral nutrition for pediatric patients: characterization of workload and costs. J. Pediatr. Pharmacol. Ther., 2012, 17(4), 389-394.
[http://dx.doi.org/10.5863/1551-6776-17.4.389] [PMID: 23411509]
[10]
Plascjak, P.S.; Kim, K.; Meyer, W., Jr; Divel, J.; Der, M.; Eckelman, W.C. An automated radiopharmaceutical dispenser. Appl. Radiat. Isot., 1997, 48(3), 345-348.
[http://dx.doi.org/10.1016/S0969-8043(96)00215-1] [PMID: 9116653]
[11]
Aslani, A.; Snowdon, G.M.; Bailey, D.L.; Schembri, G.P.; Bailey, E.A.; Roach, P.J. Gallium-68 DOTATATE production with automated PET radiopharmaceutical synthesis system: A three year experience. Asia Ocean. J. Nucl. Med. Biol., 2014, 2(2), 75-86.
[PMID: 27408863]
[12]
Dhilly, M.; Guillouet, S.; Patin, D.; Fillesoye, F.; Abbas, A.; Gourand, F.; Tirel, O.; Galateau, F.; MacKenzie, E.T.; Dumontet, C.; Leporrier, M.; Barré, L. 2-[18F]fludarabine, a novel positron emission tomography (PET) tracer for imaging lymphoma: a micro-PET study in murine models. Mol. Imaging Biol., 2014, 16(1), 118-126.
[http://dx.doi.org/10.1007/s11307-013-0659-2] [PMID: 23852402]
[13]
Millex-GP. Available from. https://www.merckmillipore.com/FR/fr/product/Millex-GP-Syringe-Filter-Unit%2C-0.22%C2%A0%C2%B5m%2C-polye-thersulfone%2C-33%C2%A0mm%2C-gammasterilized,MM_NF-SLGP033RS?ReferrerURL=https%3A%2F%2Fwww.google.fr%2F&bd=1 [Accessed Aug. 1, 2017].
[14]
Pant, G.S.; Sharma, S.K.; Rath, G.K. Finger doses for staff handling radiopharmaceuticals in nuclear medicine. J. Nucl. Med. Technol., 2006, 34(3), 169-173.
[PMID: 16951286]
[15]
Vergote, T.; Tworowska, I.; Ershadi, K.; Philippart, G.; Morelle, J.L. Radiosynthesis of 68Ga-PSMA-HBEDcc agent using Trasis MiniAiO® Synthesizer (Smartmedix TM). J. Nucl. Med., 2016, 57, 1102-1102.
[16]
Buccino, P.; Kreimerman, I.; Zirbesegger, K.; Porcal, W.; Savio, E.; Engler, H. Automated radiosynthesis of [(11)C]L-deprenyl-D2 and [(11)C]D-deprenyl using a commercial platform. Appl. Radiat. Isot., 2016, 110, 47-52.
[http://dx.doi.org/10.1016/j.apradiso.2015.12.051] [PMID: 26760951]
[17]
Ready-to-use consumables references.pdf, (n.d.).. Available from http://www.trasis.com/sites/trasis/files/datasheets/Ready-to-use%20 consumables%20references.pdf [Accessed April. 20, 2014].